Abstract
As the incidence of prostatic cancer rises, family physicians can expect to diagnose and treat increasing numbers of patients with this disease. Recent research has uncovered a new serum tumor marker (prostate-specific antigen), which is useful in patient monitoring and which eventually could be used in screening. A current review of available serum tumor markers is presented.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ayiomamitis A. Epidemiology of cancer of the prostate in Canada: 1950-1984. Br J Urol. 1987 Aug;60(2):157–161. doi: 10.1111/j.1464-410x.1987.tb04954.x. [DOI] [PubMed] [Google Scholar]
- Catalona W. J., Smith D. S., Ratliff T. L., Dodds K. M., Coplen D. E., Yuan J. J., Petros J. A., Andriole G. L. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med. 1991 Apr 25;324(17):1156–1161. doi: 10.1056/NEJM199104253241702. [DOI] [PubMed] [Google Scholar]
- Ercole C. J., Lange P. H., Mathisen M., Chiou R. K., Reddy P. K., Vessella R. L. Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer. J Urol. 1987 Nov;138(5):1181–1184. doi: 10.1016/s0022-5347(17)43543-9. [DOI] [PubMed] [Google Scholar]
- Heller J. E. Prostatic acid phosphatase: its current clinical status. J Urol. 1987 Jun;137(6):1091–1103. doi: 10.1016/s0022-5347(17)44414-4. [DOI] [PubMed] [Google Scholar]
- Lange P. H. Prostate-specific antigen for staging prior to surgery and for early detection of recurrence after surgery. Urol Clin North Am. 1990 Nov;17(4):813–817. [PubMed] [Google Scholar]
- Scardino P. T. Early detection of prostate cancer. Urol Clin North Am. 1989 Nov;16(4):635–655. [PubMed] [Google Scholar]
- Silverberg E., Lubera J. A. Cancer statistics, 1989. CA Cancer J Clin. 1989 Jan-Feb;39(1):3–20. doi: 10.3322/canjclin.39.1.3. [DOI] [PubMed] [Google Scholar]
- Stamey T. A., Kabalin J. N., Ferrari M. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. III. Radiation treated patients. J Urol. 1989 May;141(5):1084–1087. doi: 10.1016/s0022-5347(17)41176-1. [DOI] [PubMed] [Google Scholar]
- Stamey T. A., Yang N., Hay A. R., McNeal J. E., Freiha F. S., Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med. 1987 Oct 8;317(15):909–916. doi: 10.1056/NEJM198710083171501. [DOI] [PubMed] [Google Scholar]
- Wajsman Z., Klimberg I. W. Staging evaluation and follow-up of patients with advanced prostatic cancer. Semin Urol. 1988 Nov;6(4):249–261. [PubMed] [Google Scholar]